# Taurine Eye Drops May Prevent the Progression of Cataract

> **NCT06639711** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University Of Anbar** · enrollment: 50 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Taurine

## Key facts

- **NCT ID:** NCT06639711
- **Lead sponsor:** University Of Anbar
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-10
- **Primary completion:** 2024-12-20
- **Final completion:** 2024-12-20
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06639711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06639711, "Taurine Eye Drops May Prevent the Progression of Cataract". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06639711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*